Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allisartan isoproxil + amlodipine vs monotherapy in primary hypertension
CTR20210476Phase 3Completed
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allisartan isoproxil + amlodipine in essential hypertension, sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Mar 2021; status: completed.
02
Drugs
allisartan isoproxil + amlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20210476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210476.